60 http://clinicaloptions.com/HIV.aspx en-us ℗ & © 2008 Clinical Care Options CCO is your best source for the newest HIV treatment data. Clinical Care Options Audio highlights from independent conference coverage and other HIV educational programs Clinical Care Options HIV vkeane@clinicaloptions.com Clinical Care Options Stay Tuned HIV: From the Lab to the Clinic Robert Shafer, MD, discusses the use of new research tools to assess minority variants of HIV. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e3_lab.mp3 Tue, 26 Aug 2008 17:00:00 GMT 12:36 HIV, Clinic, Shafer Clinical Care Options Stay Tuned HIV: Clinical Pearl Lisa Hirschhorn, MD, provides an update on the current understanding of factors that affect adherence as well as interventions to promote adherence in patients with HIV infection. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e3_pearl.mp3 Tue, 26 Aug 2008 17:00:00 GMT 9:22 HIV, Stay Tuned, Hirschhorn Clinical Care Options Stay Tuned HIV: Advances in Diagnostics Paul E. Sax, MD, describes the latest developments in tropism assays. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e3_advances.mp3 Mon, 25 Aug 2008 17:00:00 GMT 8:23 HIV, Diagnostics, Sax Clinical Care Options Stay Tuned HIV: Expert View Point Kimberly Y. Smith, MD, MPH, provides current clinical perspective on when to initiate antiretroviral therapy in treatment-naive patients. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e3_expert.mp3 Wed, 20 Aug 2008 17:00:00 GMT 5:51 HIV,Antiretroviral,Smith Clinical Care Options Stay Tuned HIV: New This Month Daniel R. Kuritzkes, MD, reviews some of the most clinically relevant presentations from the 2008 International Drug Resistance Workshop. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e3_new.mp3 Tue, 19 Aug 2008 17:00:00 GMT 11:59 HIV, AIDS, Kuritzkes Clinical Care Options Switch Antiretrovirals or Add Lipid-Lowering Agents? Marshall J. Glesby, MD, PhD, and James H. Stein, MD, review evidence for managing HIV-infected patients with dyslipidemia--should one switch antiretroviral therapy or add lipid-lowering agents? http://clinicaloptions.com/hiv_podcast_audio_managedyslipidemia_telecon.mp3 Thu, 14 Aug 2008 17:00:00 GMT 01:01:31 HIV, Dyslipidemia, Glesby Clinical Care Options CCO HIV Stay Tuned: New This Month Stay Tuned Program Directors Kathleen E. Squires, MD, Kimberly Y. Smith, MD, MPH, and Andrew R. Zolopa, MD, offer perspective on new data on abacavir and their implications for patient management. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e2_new.mp3 Mon, 07 Jul 2008 17:00:00 GMT 9:28 HIV,Squires,Smith,Zolopa Clinical Care Options CCO HIV Stay Tuned:Clinical Pearl Sally Hodder, MD, reviews emerging pharmacokinetic data in pregnant patients that may impact development of new regimens for these patients. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e2_pearl.mp3 Thu, 03 Jul 2008 17:00:00 GMT 07:21 HIV,AIDS,Hodder Clinical Care Options CCO HIV Stay Tuned: Case of the Month Paul E. Sax, MD, guides you through the management of a moderately treatment-experienced patient with options limited by coadministered psychiatric medications. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e2_case.mp3 Tue, 01 Jul 2008 17:00:00 GMT 8:06 HIV,AIDS,Sax Clinical Care Options CCO HIV Stay Tuned: Expert Viewpoint W. David Hardy, MD, discusses decision-making strategy for choosing the optimum number of agents for virologic suppression for treatment-experienced patients. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e2_expert.mp3 Mon, 30 Jun 2008 17:00:00 GMT 7:04 HIV, AIDS, Hardy Clinical Care Options CCO HIV Stay Tuned: A Must Read Barbara Weiser, MD, and Harold Burger, PhD, MD, discuss findings of their recent paper and the implications of X4-specific viral load for patient treatment options. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e2_read.mp3 Thu, 26 Jun 2008 17:00:00 GMT 09:33 HIV, AIDS, Weiser, Burger Clinical Care Options Case of the Month - CCO HIV Stay Tuned Eric Daar, MD, challenges you to devise a decision making strategy for a highly treatment experienced-patient. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e1_case.mp3 Mon, 02 Jun 2008 17:00:00 GMT 07:55 HIV, treatment-experienced, Daar Clinical Care Options Clinical Pearl - CCO HIV Stay Tuned Carl J. Fichtenbaum, MD, discusses a step-by-step approach to initiation or modification of antiretroviral therapy. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e1_pearl.mp3 Fri, 30 May 2008 17:00:00 GMT 08:39 HIV, retrovirus, Fichtenbaum Clinical Care Options From the Lab to the Clinic - CCO HIV Stay Tuned Review a novel approach to identifying cellular proteins integral to HIV infection with Daniel Kuritzkes, MD, and Kimberly Smith, MD, MPH. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e1_lab.mp3 Thu, 29 May 2008 17:00:00 GMT 07:16 HIV, Kuritzkes, Smith Clinical Care Options Expert Viewpoint - CCO HIV Stay Tuned William G. Powderly, MD, reviews the management of the aging HIV-infected patient. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e1_expert.mp3 Wed, 28 May 2008 17:00:00 GMT 06:55 HIV, Aging, Powderly Clinical Care Options A Must Read - CCO HIV Stay Tuned Listen to Joseph K. Wong, MD, discuss treatment interruptions and the long-term risk of viral rebound. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e1_read.mp3 Tue, 27 May 2008 17:00:00 GMT 07:13 HIV, Stay Tuned, CCO, Wong Clinical Care Options New This Month - CCO HIV Stay Tuned Sharon L. Walmsley, MSc, MD, FRCPC, reviews data from the meeting in Boston. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e1_new.mp3 Thu, 22 May 2008 17:00:00 GMT 05:50 retroviruses, HIV, Stay Tuned, Walmsley Clinical Care OptionsCCO Audio Expert Highlights from the 2008 Retroviruses MeetingAndrew R. Zolopa, MD, discusses data from the STEP trial, which demonstrated that the Ad5 trivalent AIDS vaccine failed to reduce HIV-1 acquisition and may increase the risk of acquisition in an Ad5-immune subgroup of vaccine recipients.http://clinicaloptions.com/hiv_podcast_audio_Retroviruses08_zolopa.mp3Thu, 6 Mar 2008 17:00:00 GMT04:41HIV, AIDS, Zolopa Clinical Care OptionsCCO Audio Expert Highlights from the 2008 Retroviruses MeetingBruce Polsky, MD, discusses the results of an important ACTG study evaluating whether patients who present with an acute opportunistic infection should start antiretroviral therapy immediately or after treatment for the OI.http://clinicaloptions.com/hiv_podcast_audio_Retroviruses08_polsky.mp3Wed, 5 Mar 2008 17:00:00 GMT 07:14HIV, ACTG, Polsky Clinical Care OptionsCCO Audio Expert Highlights from the 2008 Retroviruses MeetingJoel E. Gallant, MD, MPH, reviews highlights of reports on first-line therapies from the 2008 Conference on Retroviruses and Opportunistic Infections.http://clinicaloptions.com/hiv_podcast_audio_Retroviruses08_gallant.mp3Thu, 28 Feb 2008 17:00:00 GMT07:22HIV, Retrovirus, Gallant Clinical Care OptionsCCO Audio Expert Highlights from the 2008 Retroviruses Meeting Joseph J. Eron, Jr., MD, comments on how the "new kids on the block"-maraviroc, raltegravir, and etravirine-have "grown up" with 48-week data being reported at this meeting.http://clinicaloptions.com/hiv_podcast_audio_Retroviruses08_eron.mp3Tue, 26 Feb 2008 17:00:00 GMT 04:25HIV, Eron Clinical Care Options CCO Audio Expert Highlights from the 2008 Retroviruses Meeting Judith S. Currier, MD, MSc, reviews highlights of reports on initial therapy, complications of antiretroviral therapy, and other key topics from the 2008 Retroviruses meeting. http://clinicaloptions.com/hiv_podcast_audio_Retroviruses08_currier.mp3 Fri, 22 Feb 2008 17:00:00 GMT 05:15 HIV, antiretroviral, Currier Clinical Care Options Expert Highlights from the ID Meeting in Chicago Joseph J. Eron, Jr., MD, discusses new data presented in Chicago from the ARTEMIS study comparing the boosted protease inhibitor darunavir/ritonavir with the fixed-dose protease inhibitor lopinavir/ritonavir. http://clinicaloptions.com/hiv_podcast_audio_Chicago07_eron.mp3 Tue, 9 Oct 2007 17:00:00 GMT 4:08 HIV, Daar, retroviruses, AIDS Clinical Care Options Expert Highlights from the ID Meeting in Chicago Trevor Hawkins, MD, reports on efficacy and safety data presented in Chicago on the investigational antiretroviral integrase inhibitors raltegravir and elvitegravir. http://clinicaloptions.com/hiv_podcast_audio_Chicago07_hawkins.mp3 Mon, 8 Oct 2007 17:00:00 GMT 7:57 HIV, Daar, retroviruses, AIDS Clinical Care Options Expert Highlights from the ID Meeting in Chicago Eric S. Daar, MD, discusses reports on viral tropism and tropism assays and the various types of viral entry inhibitors that were presented at the conference in Chicago. http://clinicaloptions.com/hiv_podcast_audio_Chicago07_daar.mp3 Fri, 5 Oct 2007 17:00:00 GMT 12:19 HIV, Daar, retroviruses, AIDS Clinical Care Options Expert Highlights from the ID Meeting in Chicago Joel E. Gallant, MD, MPH, discusses how data presented in Chicago may impact decision making on when to begin antiretroviral therapy. http://clinicaloptions.com/hiv_podcast_audio_Chicago07_gallant.mp3 Thu, 4 Oct 2007 17:00:00 GMT 4:38 HIV, Gallant, retroviruses, AIDS Clinical Care Options Audio highlights from the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention Joel E. Gallant, MD, MPH, reviews new cohort data that may strengthen the growing argument for earlier therapy. http://clinicaloptions.com/hiv_podcast_audio_IAS2007_gallant.mp3 Wed, 29 Aug 2007 17:00:00 GMT 7:28 HIV, Gallant, retroviruses, IAS, AIDS Clinical Care Options Audio highlights from the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention Andrew Carr, MD, discusses the long-awaited results of the PREDICT-1 trial as well as other data presented in an oral session on adverse events of ART. http://clinicaloptions.com/hiv_podcast_audio_IAS2007_carr.mp3 Tue, 28 Aug 2007 17:00:00 GMT 7:45 HIV, Carr, retroviruses, IAS, AIDS Clinical Care Options Audio highlights from the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention Daniel R. Kuritzkes, MD, summarizes emerging data from presentations about resistance to newer drugs such as CCR5 antagonists, etravirine, and integrase inhibitors. http://clinicaloptions.com/hiv_podcast_audio_IAS2007_kuritzkes.mp3 Thu, 16 Aug 2007 17:00:00 GMT 11:29 HIV, Kuritzkes, retroviruses, IAS, AIDS Clinical Care Options Audio highlights from the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention Brian Gazzard, MA, MD, FRCP, describes data from several posters on the treatment of ARV-experienced patients. http://clinicaloptions.com/hiv_podcast_audio_IAS2007_gazzard.mp3 Thu, 23 Aug 2007 17:00:00 GMT 6:10 HIV, Gazzard, retroviruses, IAS, AIDS Clinical Care Options Audio highlights from the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention Thomas Quinn, MD, MSc, describes the results of the final reports of the 3 large circumcision trials and the effect of this intervention on preventing HIV acquisition in males. http://clinicaloptions.com/hiv_podcast_audio_IAS2007_quinn.mp3 Tue, 21 Aug 2007 17:00:00 GMT 16:41 HIV, Quinn, retroviruses, IAS, AIDS Clinical Care Options Audio highlights from the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention Hoosen Coovadia, MBBS, MD, reviews data investigating strategies to decrease transmission by breastfeeding of HIV from mothers who are HIV infected to their infants. http://clinicaloptions.com/hiv_podcast_audio_IAS2007_coovadia.mp3 Mon, 20 Aug 2007 17:00:00 GMT 5:24 HIV, Coovadia, retroviruses, IAS, AIDS Clinical Care Options Audio highlights from the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention Vicente Soriano, MD, PhD, provides an overview of several presentations that address the treatment of HIV and hepatitis coinfection. http://clinicaloptions.com/hiv_podcast_audio_IAS2007_soriano.mp3 Fri, 17 Aug 2007 17:00:00 GMT 10:12 HIV, Soriano, retroviruses, IAS, AIDS Clinical Care Options Audio highlights from the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention Eric S. Daar, MD, summarizes results of several ongoing clinical trials of antiretroviral therapy in both treatment-naive and treatment-experienced patients. http://clinicaloptions.com/hiv_podcast_audio_IAS2007_daar.mp3 Thu, 16 Aug 2007 17:00:00 GMT 9:16 HIV, Daar, retroviruses, IAS, AIDS Clinical Care Options Audio highlights from the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention David A. Cooper, MD, DSc, remarks on presentations addressing the pros and cons of early treatment, both in the developed and developing world. http://clinicaloptions.com/hiv_podcast_audio_IAS2007_cooper.mp3 Wed, 15 Aug 2007 17:00:00 GMT 8:53 HIV, Cooper, retroviruses, IAS, AIDS Clinical Care Options Audio highlights from the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention Richard E. Chaisson, MD, discusses new data presented on TB and HIV including such topics as immune reconstitution inflammatory syndrome and combining TB and HIV therapy. http://clinicaloptions.com/hiv_podcast_audio_IAS2007_chaisson.mp3 Tue, 14 Aug 2007 17:00:00 GMT 13:24 HIV, Chaisson, retroviruses, IAS, AIDS. Tuberculosis Clinical Care Options Audio highlights from the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention Joel E. Gallant, MD, MPH, reports on first-line therapy by reviewing posters on this subject, including important updates on GS934, ALERT, BMS-089, and GS903E. http://clinicaloptions.com/hiv_podcast_audio_IAS2007_gallant2.mp3 Thu, 9 Aug 2007 17:00:00 GMT 8:55 HIV, Gallant, retroviruses, IAS, AIDS Clinical Care Options Audio highlights from the 2007 retrovirus meeting in Los Angeles Joel Gallant, MD, MPH, discusses the phase IIb comparison of TMC278, a second generation NNRTI, with efavirenz in antiretroviral-naive patients and notes that this agent may challenge efavirenz in this arena. http://clinicaloptions.com/hiv_podcast_audio_retrovirus2007_gallant.mp3 Fri, 16 Feb 2007 17:00:00 GMT 3:11 HIV, Gallant, retroviruses, NNRTI Clinical Care Options Audio highlights from the 2007 retrovirus meeting in Los Angeles W. David Hardy, MD, discusses the results of phase 3 studies of raltegravir (MK-0518) and maraviroc in triple-class-experienced patients, and highlights the availability of these agents, as well as etravirine, through expanded access programs. http://clinicaloptions.com/hiv_podcast_audio_retrovirus2007_hardy.mp3 Wed, 14 Feb 2007 17:00:00 GMT 3:16 HIV, Hardy, retroviruses Clinical Care Options Audio highlights from the 2007 retrovirus meeting in Los Angeles Bruce Polsky, MD, reviews key presentations on the management of coinfections in HIV-infected patients including TB related testing, morbidity and mortality, impact of unsafe sexual practices on acute HCV infection in MSM and surprising results which may impact the use of entecavir for the treatment of HBV/HIV coinfected patients. http://clinicaloptions.com/hiv_podcast_audio_retrovirus2007_polsky.mp3 Tue, 13 Feb 2007 17:00:00 GMT 10:57 HIV, Polsky, retroviruses, HCV, HBV, Hepatitis, Coinfection Clinical Care Options Audio highlights from the 2007 retrovirus meeting in Los Angeles Judith S. Currier, MD, MSc, reviews data from 2 antiretroviral clinical studies that provide information on strategies to decrease treatment-related lipoatrophy in HIV-infected patients. http://clinicaloptions.com/hiv_podcast_audio_retrovirus2007_currier.mp3 Mon, 12 Feb 2007 17:00:00 GMT 4:25 HIV, Currier, retroviruses, lipoatrophy Clinical Care Options Audio highlights from the 2007 retrovirus meeting in Los Angeles Joseph J. Eron, Jr, MD, notes that there were very few reports on drugs in early clinical development at this meeting and discusses the implications of that for treatment of highly experienced patients. http://clinicaloptions.com/hiv_podcast_audio_retrovirus2007_eron.mp3 Fri, 9 Feb 2007 17:00:00 GMT 3:27 HIV, Eron, retroviruses Clinical Care Options Audio highlights from the San Francisco meeting Sally Hodder, MD, summarizes new data on the novel integrase inhibitor, MK-0518, showing the investigational drug had no discernible effect on lipid levels in a phase II study involving treatment-naive patients. http://clinicaloptions.com/hiv_podcast_audio_sfo2006_hodder.mp3 Tue, 7 Nov 2006 17:00:00 GMT 3:08 HIV, Hodder, retroviruses Clinical Care Options Audio highlights from the San Francisco meeting Donald P. Kotler, MD, discusses diagnosis of the Metabolic Syndrome in people with HIV infection and reports new information from the recent Lipodystrophy Workshop regarding the efficacy of dietary and lifestyle interventions in HIV-infected patients. http://clinicaloptions.com/hiv_podcast_audio_sfo2006_kotler.mp3 Tue, 7 Nov 2006 17:00:00 GMT 5:38 HIV, Kotler, retroviruses Clinical Care Options Audio highlights from the San Francisco meeting Joel E. Gallant, MD, MPH, describes how new cohort data from Spain has contributed to the evolving debate on when is the best time to start antiretroviral therapy in treatment-naive patients. http://clinicaloptions.com/hiv_podcast_audio_sfo2006_gallant.mp3 Tue, 7 Nov 2006 17:00:00 GMT 3:05 HIV, Gallant, retroviruses Clinical Care Options Audio highlights from the IAC meeting in Toronto W. David Hardy, MD, reports short-term safety and efficacy data from phase II studies of maraviroc and vicriviroc, investigational CCR5 antagonists and contenders to be the next novel class of HIV therapeutics to reach clinical practice. http://clinicaloptions.com/hiv_podcast_audio_iac2006_hardy.mp3 Tue, 5 Sep 2006 17:00:00 GMT 5:26 HIV, Hardy, retroviruses, IAC Clinical Care Options Audio highlights from the IAC meeting in Toronto Joseph J. Eron, Jr., MD, examines data on lopinavir/ritonavir monotherapy and considers the apparent risks and benefits of this experimental treatment simplification strategy compared with conventional use of HAART. http://clinicaloptions.com/hiv_podcast_audio_iac2006_eron.mp3 Fri, 1 Sep 2006 17:00:00 GMT 5:56 HIV, Eron, retroviruses, IAC Clinical Care Options Audio highlights from the IAC meeting in Toronto Charles van der Horst, MD, explores provocative new reports on the relationship between herpes simplex virus infection and risk of HIV transmission, and their implications for HIV prevention programs. http://clinicaloptions.com/hiv_podcast_audio_iac2006_vanderhorst.mp3 Tue, 29 Aug 2006 17:00:00 GMT 3:17 HIV, van der Horst, retroviruses, IAC Clinical Care Options Audio highlights from the IAC meeting in Toronto Jürgen K. Rockstroh, MD, considers the implications of a new study from Germany, involving patients with acute HIV infection, for use of antiretroviral therapy in people who present with primary infection. http://clinicaloptions.com/hiv_podcast_audio_iac2006_rockstroh.mp3 Mon, 28 Aug 2006 17:00:00 GMT 4:01 HIV, Rockstroh, retroviruses, IAC Clinical Care Options Audio highlights from the IAC meeting in Toronto Dr. Mark A. Wainberg, explains why he thinks integrase inhibitors may prove to be among the major scientific breakthroughs in management of HIV disease to be reported at the IAC conference. http://clinicaloptions.com/hiv_podcast_audio_iac2006_wainberg2.mp3 Mon, 28 Aug 2006 17:00:00 GMT 6:07 HIV, Wainberg, retroviruses, IAC Clinical Care Options Audio highlights from the IAC meeting in Toronto Joel E. Gallant, MD, MPH, discusses the findings of a series of major clinical trials evaluating antiretroviral treatment options for use in first-line therapy for patients with HIV infection. http://clinicaloptions.com/hiv_podcast_audio_iac2006_gallant.mp3 Fri, 25 Aug 2006 17:00:00 GMT 6:37 HIV, Gallant, retroviruses, IAC Clinical Care Options Audio highlights from the IAC meeting in Toronto Sally Hodder, MD, summarizes data from the ALIVE cohort showing that while HAART has reduced the incidence of community-acquired pneumonia in intravenous drug users, this patient group remains at high risk. http://clinicaloptions.com/hiv_podcast_audio_iac2006_hodder.mp3 Tue, 29 Aug 2006 17:00:00 GMT 4:21 HIV, Hodder, retroviruses, IAC Clinical Care Options Audio highlights from the IAC meeting in Toronto Judith S. Currier, MD, MSc, reviews data from Zambia and Thailand describing outcomes observed in women treated with NNRTI-containing therapy following receipt of nevirapine during pregnancy. http://clinicaloptions.com/hiv_podcast_audio_iac2006_currier.mp3 Wed, 23 Aug 2006 17:00:00 GMT 4:44 HIV, Currier, retroviruses, IAC Clinical Care Options Audio highlights from the IAC meeting in Toronto Mark A. Wainberg, Co-Chair of the XVI International AIDS Conference, speaks about his hopes for how the Toronto meeting will galvanize support for treatment access programs for people living with HIV/AIDS in resource-limited settings. http://clinicaloptions.com/hiv_podcast_audio_iac2006_wainberg1.mp3 Tue, 22 Aug 2006 17:00:00 GMT 3:14 HIV, Wainberg, retroviruses, IAC Clinical Care Options Audio highlights from the IAC meeting in Toronto Richard E. Chaisson, MD, discusses new evidence from Rio de Janeiro, Brazil, demonstrating that use of HAART plus preventive therapy for TB is more effective than either intervention alone in reducing the incidence of TB among HIV-infected patients. http://clinicaloptions.com/hiv_podcast_audio_iac2006_chaisson.mp3 Tue, 22 Aug 2006 17:00:00 GMT 6:16 HIV, Chaisson, retroviruses, IAC Clinical Care Options Independent highlights from the Retroviruses meeting in Washington D.C. Joel E. Gallant, MD, MPH, discusses the final results of the ACTG 5095 study, and describes promising new data on investigational agents from novel drug classes. http://clinicaloptions.com/hiv_podcast_audio_DC05_gallant.mp3 Mon, 6 Mar 2006 17:00:00 GMT 4:04 HIV, Gallant, retroviruses Clinical Care Options Independent highlights from the Retroviruses meeting in Washington D.C. Sally Hodder, MD summarizes 3 new analyses from the APRICOT study of pegylated interferon plus ribavirin in patients with HIV/HCV coinfection. http://clinicaloptions.com/hiv_podcast_audio_DC05_hodder.mp3 Mon, 27 Feb 2006 17:00:00 GMT 4:15 HIV, HCV, coinfection, Hodder Clinical Care Options Independent highlights from the Retroviruses meeting in Denver Kimberly Y. Smith, MD, MPH, reviews some of the highs and lows of Denver 2006 - progress in drug development contrasted by alarming epidemiological trends among African American gay men. http://clinicaloptions.com/hiv_podcast_audio_Denver06_smith.mp3 Fri, 10 Feb 2006 17:00:00 GMT 3:48 HIV, Smith, retroviruses, drug development, epidemiology Clinical Care Options Independent highlights from the Retroviruses meeting in Denver Joseph J, Eron, Jr., MD, describes promising preliminary data on two candidate agents from a new antiretroviral class, integrase inhibitors: MK-0518 and GS-9137. http://clinicaloptions.com/hiv_podcast_audio_Denver06_eron.mp3 Fri, 10 Feb 2006 17:00:00 GMT 3:48 HIV, Eron, retroviruses, antiretroviral, integrase inhibitors Clinical Care Options Independent highlights from the Retroviruses meeting in Denver Sally Hodder, MD, summarizes provocative data from South Africa demonstrating a reduction in the incidence of tuberculosis in adults and children following the introduction of HAART. http://clinicaloptions.com/hiv_podcast_audio_Denver06_hodder.mp3 Fri, 10 Feb 2006 17:00:00 GMT 3:48 HIV, Hodder, retroviruses, HAART, tuberculosis Clinical Care Options Independent highlights from the Retroviruses meeting in Denver Joel E. Gallant, MD, MPH, discusses the results of SMART, a large international trial investigating CD4-guided intermittent therapy whose recent closure proved to be a major talking point. http://clinicaloptions.com/hiv_podcast_audio_Denver06_gallant.mp3 Fri, 10 Feb 2006 17:00:00 GMT 3:41 HIV, Gallant, retroviruses, CD4-guided fibrosis Clinical Care Options Independent highlights from the ID meeting in Washington, D.C. Donald P. Kotler, MD describes the work of Spanish investigators who have evaluated the clinical utility of a noninvasive method of fibrosis monitoring in HIV/HCV coinfected patients. http://clinicaloptions.com/hiv_podcast_DC05_kotler.mp3 Wed, 8 Feb 2006 17:00:00 GMT 4:03 HIV, Kotler, coinfection, fibrosis Clinical Care Options Independent highlights from the meeting in Dublin Ian M. Sanne, MBBCH, FCP(SA), summarizes the results of phase II studies of TMC125, an investigational NNRTI that demonstrated activity in patients with resistance to existing NNRTI agents. http://clinicaloptions.com/HIV_podcast_dublin05_sanne.mp3 Fri, 3 Feb 2006 17:00:00 GMT 2:48 HIV, Sanne, Dublin, NRTI, resistance Clinical Care Options Independent highlights from the meeting in Dublin W. David Hardy, MD, describes the findings of a trial comparing initial NRTI-sparing therapy compared with standard triple therapy and a study of immunologic responses to first-line therapy with either PI- or NNRTI-based regimens in patients who present with low CD4+ cell counts. http://clinicaloptions.com/HIV_podcast_dublin05_hardy.mp3 Fri, 3 Feb 2006 17:00:00 GMT 3:02 HIV, Hardy, Dublin, NRTI, cell counts Clinical Care Options Audio highlights from the 2008 International AIDS Conference Daniel R. Kuritzkes, MD, highlights clinically relevant data from key studies presented at the 2008 International AIDS Conference Late Breaker Sessions. http://clinicaloptions.com/hiv_podcast_audio_MexicoCity2008_Kuritzkes.mp3 Thu, 28 Aug 2008 17:00:00 GMT 12:39 HIV, Kuritzkes, retroviruses, IAS, AIDS Clinical Care Options Audio highlights from the 2008 International AIDS Conference Anton L. Pozniak, MD, FRCP, reviews data from studies investigating antiretroviral resistance in resource-limited countries. http://clinicaloptions.com/hiv_podcast_audio_MexicoCity2008_Pozniak.mp3 Fri, 12 Sep 2008 17:00:00 GMT 3:31 HIV, Pozniak, retroviruses, IAS, AIDS Clinical Care Options Audio highlights from the 2008 International AIDS Conference Kathleen E. Squires, MD, recaps studies that will likely impact the management of HIV-infected women while she was on location at the 2008 International AIDS Conference. http://clinicaloptions.com/hiv_podcast_audio_MexicoCity2008_Squires.mp3 Fri, 12 Sep 2008 17:00:00 GMT 3:54 HIV, Squires, retroviruses, IAS, AIDS Clinical Care Options Audio highlights from the 2008 International AIDS Conference While on location at the 2008 International AIDS Conference, Pedro Cahn, MD, PhD, commented on the clinical implications of several studies presented at the conference. http://clinicaloptions.com/hiv_podcast_audio_MexicoCity2008_Cahn.mp3 Tue, 23 Sep 2008 17:00:00 GMT 6:04 HIV, Cahn, retroviruses, IAC Clinical Care Options Audio highlights from the 2008 International AIDS Conference Joel E. Gallant, MD, reviews clinically relevant data from presentations on first-line antiretroviral therapy from the 2008 International AIDS Conference. http://clinicaloptions.com/hiv_podcast_audio_MexicoCity2008_Gallant.mp3 Wed, 24 Sep 2008 17:00:00 GMT 5:21 HIV, Gallant, retroviruses, IAC Clinical Care Options Audio highlights from the 2008 International AIDS Conference Kimberly Y. Smith, MD, MPH, discusses the efficacy and safety data from 3 studies presented at the 2008 International AIDS Conference, each investigating newer antiretroviral agents compared with efavirenz in treatment-naive patients. http://clinicaloptions.com/hiv_podcast_audio_MexicoCity2008_Smith.mp3 Wed, 24 Sep 2008 17:00:00 GMT 6:55 HIV, Smith, retroviruses, IAC Clinical Care Options Audio highlights from the 2008 International AIDS Conference Jurgen K. Rockstroh, MD, discusses the results of key reports on HIV comorbidities from the 2008 International AIDS Conference, including the incidence and treatment of tuberculosis as well as hepatitis in HIV-coinfected patients. http://clinicaloptions.com/hiv_podcast_audio_MexicoCity2008_Rockstroh.mp3 Wed, 1 Oct 2008 17:00:00 GMT 10:12 HIV, Rockstroh, retroviruses, IAC Clinical Care Options Audio highlights from the 2008 International AIDS Conference Jose Gatell, MD, provides an overview of presentations on the new IAS treatment guidelines, HAART-associated complications, and tuberculosis coinfection, and then speculates on the future of an HIV vaccine. http://clinicaloptions.com/hiv_podcast_audio_MexicoCity2008_Gatell.mp3 Wed, 1 Oct 2008 17:00:00 GMT 8:00 HIV, Gatell, retroviruses, IAC Clinical Care Options Audio highlights from the 2008 International AIDS Conference Sharon L. Walmsley, MSc, MD, FRCPC, gives an overview of the top issues and studies that will be presented at this year's International AIDS Conference. http://clinicaloptions.com/hiv_podcast_audio_MexicoCity2008_Walmsley.mp3 Wed, 1 Oct 2008 17:00:00 GMT 3:23 HIV, Walmsley, retroviruses, IAC Clinical Care Options Audio highlights from the 2008 International AIDS Conference Mauro Schechter, MD, PhD, highlights what he expects to be some of the most important presentations at this year's International AIDS Conference. http://clinicaloptions.com/hiv_podcast_audio_MexicoCity2008_Schechter.mp3 Wed, 1 Oct 2008 17:00:00 GMT 2:31 HIV, Schecter, retroviruses, IAC Clinical Care Options Stay Tuned HIV: New This Month Andrew R. Zolopa, MD, and Kimberly Y. Smith, MD, MPH, offer their perspectives on the potential clinical implications of the new data on abacavir and cardiovascular risk presented at the 2008 International AIDS Conference in Mexico City. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e4_new1.mp3 Thu, 9 Oct 2008 17:00:00 GMT 15:28 HIV,AIDS,Zolopa,Smith Clinical Care Options Stay Tuned HIV: New This Month Joseph J. Eron, Jr., MD, summarizes key presentations from the 2008 International AIDS Conference that are likely to impact the management of treatment-experienced patients. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e4_new.mp3 Thu, 9 Oct 2008 17:00:00 GMT 10:19 HIV,AIDS,Eron Clinical Care Options Stay Tuned HIV: Expert Viewpoint Anton L. Pozniak, MD, FRCP, who is a panel member for the European AIDS Clinical Society and British HIV Association guidelines, provides insight on when to start antiretroviral therapy and explains why differences may exist between guidelines on which agents to use in treatment-naive patients. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e4_expert.mp3 Thu, 9 Oct 2008 17:00:00 GMT 6:51 HIV,AIDS,Pozniak Clinical Care Options Stay Tuned HIV: From the Lab to the Clinic Andrew Carr, MBBS, MD, FRACP, FRCP, discusses recent data regarding markers of inflammation and other processes that are associated with atherosclerosis and cardiovascular disease in HIV-infected patients. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e4_lab.mp3 Thu, 9 Oct 2008 17:00:00 GMT 10:42 HIV,AIDS,Carr Clinical Care Options Stay Tuned HIV: Clinical Pearl Mauro Schechter, MD, PhD, discusses the controversial question of when to start antiretroviral therapy in TB and HIV coinfected patients. http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e4_pearl.mp3 Wed, 15 Oct 2008 17:00:00 GMT 2:31 HIV,AIDS,Schechter Clinical Care Options Audio highlights from the 2008 ICAAC/IDSA meeting in Washington D.C. Anton L. Pozniak, MD, FRCP, reports on the 96-week results from the CASTLE, ARTEMIS, and HEAT clinical trials in treatment-naive patients as well as several analyses on the use of abacavir in patients with high HIV-1 RNA. http://clinicaloptions.com/hiv_podcast_audio_Washington2008_Pozniak.mp3 Tue, 11 Nov 2008 17:00:00 GMT 8:33 HIV,ICAAC/IDSA,Pozniak Clinical Care Options Audio highlights from the 2008 ICAAC/IDSA meeting in Washington D.C. Sharon L. Walmsley, MSc, MD, FRCPC, reports on several analyses from clinical trials that inform on the assessment of activity of antiretroviral agents in treatment-experienced patients and the optimal construction of regimens for these patients. http://clinicaloptions.com/hiv_podcast_audio_Washington2008_Walmsley.mp3 Tue, 11 Nov 2008 17:00:00 GMT 10:45 HIV,ICAAC/IDSA,Walmsley Clinical Care Options Audio highlights from the 2008 ICAAC/IDSA meeting in Washington D.C. Daniel R. Kuritzkes, MD, discusses new data on raltegravir mechanism of action, resistance to integrase inhibitors, viral tropism, and prevalence of the K65R mutation in populations with subtype C virus. http://clinicaloptions.com/hiv_podcast_audio_Washington2008_Kuritzkes.mp3 Tue, 11 Nov 2008 17:00:00 GMT 15:07 HIV,ICAAC/IDSA,Kuritzkes Clinical Care Options Audio highlights from the 2008 ICAAC/IDSA meeting in Washington D.C. Joseph J. Eron, Jr., MD, describes new data on the investigational maturation inhibitor bevirimat and entry inhibitor PRO 140 and discusses the reanalysis of data from the MERIT trial. http://clinicaloptions.com/hiv_podcast_audio_Washington2008_Eron.mp3 Tue, 11 Nov 2008 17:00:00 GMT 13:39 HIV,ICAAC/IDSA,Eron Clinical Care Options Audio highlights from the 2008 ICAAC/IDSA meeting in Washington D.C. Joel E. Gallant, MD, MPH, reports on the phase III STARTMRK trial of raltegravir vs efavirenz in antiretroviral-naive patients and on the NA-ACCORD cohort study on when to start antiretroviral therapy. http://clinicaloptions.com/hiv_podcast_audio_Washington2008_Gallant.mp3 Tue, 11 Nov 2008 17:00:00 GMT 8:20 HIV,ICAAC/IDSA,Gallant Clinical Care Options Audio highlights from the 2008 ICAAC/IDSA meeting in Washington D.C. Paul E. Sax, MD, reviews real-world trials of newer agents in the treatment of antiretroviral patients. http://clinicaloptions.com/hiv_podcast_audio_Washington2008_Sax.mp3 Thu, 20 Nov 2008 17:00:00 GMT 7:01 HIV,ICAAC/IDSA,Sax Clinical Care Options Audio highlights from the 2008 ICAAC/IDSA meeting in Washington D.C. Eric S. Daar, MD, gives an overview of several trials of antiretroviral-naive patients and discusses new information that may inform on when to start therapy. http://clinicaloptions.com/hiv_podcast_audio_Washington2008_Daar.mp3 Thu, 20 Nov 2008 17:00:00 GMT 7:41 HIV,ICAAC/IDSA,Daar Clinical Care Options Audio highlights from the 2008 ICAAC/IDSA meeting in Washington D.C. William G. Powderly, MD, discusses interesting data on bone metabolism from the SMART study and several key papers about diabetes in HIV-infected patients. http://clinicaloptions.com/hiv_podcast_audio_Washington2008_Powderly.mp3 Thu, 20 Nov 2008 17:00:00 GMT 8:55 HIV,ICAAC/IDSA,Powderly Clinical Care Options Audio highlights from the 2008 ICAAC/IDSA meeting in Washington D.C. Bruce Polsky, MD, discusses the use of fixed-dose tenofovir/emtricitabine for the treatment of HIV/HBV-coinfected patients and the failure of high ribavirin doses to provide increased ribavirin exposure when given with erythropoietin. http://clinicaloptions.com/hiv_podcast_audio_Washington2008_Polsky.mp3 Thu, 20 Nov 2008 17:00:00 GMT 8:24 HIV,ICAAC/IDSA,Polsky Clinical Care Options Audio highlights from the 2008 ICAAC/IDSA meeting in Washington D.C. Sally Hodder, MD, reviews a promising study of TMC207, an investigational drug for treatment of tuberculosis, and also reports disappointing results of a study of isoniazid treatment in children in South Africa. http://clinicaloptions.com/hiv_podcast_audio_Washington2008_Hodder.mp3 Thu, 20 Nov 2008 17:00:00 GMT 5:04 HIV,ICAAC/IDSA,Hodder Clinical Care Options Audio highlights from the 2009 Conference on Retroviruses and Opportunistic Infections in Montreal Joel E. Gallant, MD, MPH, reviews results from NA-ACCORD, the ART Cohort Collaboration, that provide additional data to consider when determining when to initiate antiretroviral therapy. http://clinicaloptions.com/hiv_podcast_audio_retroviruses2009_Gallant.mp3 Thu, 19 Feb 2009 17:00:00 GMT 7:48 HIV,CROI,Gallant Clinical Care Options Audio highlights from the 2009 Conference on Retroviruses and Opportunistic Infections in Montreal Kimberly Y. Smith, MD, MPH, describes these interesting results from the SWITCHMRK trial. http://clinicaloptions.com/hiv_podcast_audio_retroviruses2009_Smith.mp3 Thu, 19 Feb 2009 17:00:00 GMT 7:06 HIV,CROI,Smith